# A Study to Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in Taiwan

Study · id `cardio:ct-nct06925100` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06925100](<https://clinicaltrials.gov/study/NCT06925100>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06925100

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.

## Technical summary

Registry record NCT06925100. Allocation not applicable; no masking; primary purpose treatment. Start 2025-04-01 (actual); primary completion 2025-10-15 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 180 participants (enrolled count; ClinicalTrials.gov record NCT06925100, source copy `cardio:ctgov-nct06925100-2025-12-08`, retrieved 2026-10-31)
- Started: 2025-04-01 (actual) (ClinicalTrials.gov record NCT06925100, source copy `cardio:ctgov-nct06925100-2025-12-08`, retrieved 2026-10-31)
- Primary completion: 2025-10-15 (actual) (ClinicalTrials.gov record NCT06925100, source copy `cardio:ctgov-nct06925100-2025-12-08`, retrieved 2026-10-31)
- Completion: 2025-10-15 (actual) (ClinicalTrials.gov record NCT06925100, source copy `cardio:ctgov-nct06925100-2025-12-08`, retrieved 2026-10-31)
- Countries: Taiwan (ClinicalTrials.gov record NCT06925100, source copy `cardio:ctgov-nct06925100-2025-12-08`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06925100-2025-12-08`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Study to Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in Taiwan
- Acronym: CLEAR Taiwan
- Condition: Primary Hypercholesterolemia or Mixed Hyperlipidemia
- Intervention (Drug): Bempedoic acid 180 mg tablet
- Lead sponsor: Daiichi Sankyo
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Bempedoic acid (`cardio:bempedoic-acid`)
- Registry lists this organization as the lead sponsor: Daiichi Sankyo (`cardio:org-daiichi-sankyo`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effectiveness and Safety of Bempedoic Acid in Taiwanese Patients With Hypercholesterolemia: A Pragmatic Phase 4 Study (CLEAR Taiwan Study) (`cardio:pubmed-42134976`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: ae2ffb0d655bb3c5ccd31b9cdbb705df5a0aee39d4b3542221cd4a3a061ec065
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
